Edward Wolin, MD, discusses the current treatment landscape of neuroendocrine tumors.
Edward Wolin, MD
Advertisement
Articles by Edward Wolin, MD
Edward Wolin, MD, discusses the safety profile of 177Lu-dotatate in patients with advanced neuroendocrine tumors.
Advertisement
Latest Updated Articles
Dr. Wolin on the Safety of Lutathera in Advanced NETsOctober 2nd 2020
Dr. Wolin on the Treatment Landscape of NETsOctober 29th 2020
Advertisement
Advertisement
Trending on OncLive
1
Durvalumab Plus Tarlatamab Boosts Survival as First-Line ES-SCLC Maintenance
2
Arlo-Cel Meets ORR End Point in BCMA-Pretreated, Quadruple-Class Exposed R/R Myeloma
3
Camidge and Singhi Highlight the Lung Cancer Abstracts to Watch at WCLC 2026
4
Frontline Mipletamig Triplet Drives Clinical Benefit in TP53-Mutated AML
5